BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mnif MF, Kamoun M, Mnif F, Charfi N, Naceur BB, Kallel N, Rekik N, Mnif Z, Sfar MH, Sfar MT, Hachicha M, Abid M. Metabolic profile and cardiovascular risk factors in adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Indian J Endocrinol Metab 2012;16:939-46. [PMID: 23226639 DOI: 10.4103/2230-8210.102995] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Özdemir R, Korkmaz HA, Küçük M, Karadeniz C, Meşe T, Özkan B. Assessment of early atherosclerosis and left ventricular dysfunction in children with 21-hydroxylase deficiency. Clin Endocrinol 2017;86:473-9. [DOI: 10.1111/cen.13275] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
2 Amr NH, Ahmed AY, Ibrahim YA. Carotid intima media thickness and other cardiovascular risk factors in children with congenital adrenal hyperplasia. J Endocrinol Invest 2014;37:1001-8. [PMID: 25112902 DOI: 10.1007/s40618-014-0148-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
3 Tuhan H, Demircan T, Altıncık A, Çatlı G, Kızılca Ö, Egeli T, Kır M, Can Ş, Dündar B, Böber E, Abacı A. Impaired systolic and diastolic left ventricular function in children and adolescents with congenital adrenal hyperplasia receiving corticosteroid therapy. Cardiol Young 2019;29:319-24. [PMID: 30675832 DOI: 10.1017/S1047951118002330] [Reference Citation Analysis]
4 Kurnaz E, Çetinkaya S, Özalkak Ş, Bayramoğlu E, Demirci G, Öztürk HS, Erdeve ŞS, Aycan Z. Serum Fetuin-A and Insulin Levels in Classic Congenital Adrenal Hyperplasia. Horm Metab Res 2020;52:654-9. [PMID: 32108931 DOI: 10.1055/a-1116-2173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Mooij CF, van Herwaarden AE, Sweep FC, Roeleveld N, de Korte CL, Kapusta L, Claahsen-van der Grinten HL. Cardiovascular and metabolic risk in pediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency. Journal of Pediatric Endocrinology and Metabolism 2017;30. [DOI: 10.1515/jpem-2017-0068] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
6 Ntali G, Charisis S, Kylafi CF, Vogiatzi E, Michala L. The way toward adulthood for females with nonclassic congenital adrenal hyperplasia. Endocrine 2021;73:16-30. [PMID: 33855677 DOI: 10.1007/s12020-021-02715-z] [Reference Citation Analysis]
7 Maccabee-Ryaboy N, Thomas W, Kyllo J, Lteif A, Petryk A, Gonzalez-Bolanos MT, Hindmarsh PC, Sarafoglou K. Hypertension in children with congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 2016;85:528-34. [PMID: 27105393 DOI: 10.1111/cen.13086] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]